{"id":"W4220707089","doi":"10.1016/j.jaip.2022.02.026","title":"Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases","year":2022,"lang":"en","type":"article","venue":"The Journal of Allergy and Clinical Immunology In Practice","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Sanofi Genzyme; Genentech; LEO Pharma; GlaxoSmithKline; Merck; MedImmune; Vanda Pharmaceuticals; Amgen; Boehringer Ingelheim; Regeneron Pharmaceuticals; Novartis; Galderma; AstraZeneca; Pfizer; DalCor Pharmaceuticals; Sanofi","keywords":"Medicine; Dupilumab; Eczema Area and Severity Index; Dermatology Life Quality Index; Atopic dermatitis; Asthma; Placebo; Internal medicine; Quality of life (healthcare); Severity of illness; Bronchodilator; Gastroenterology; Dermatology; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003351357,0.0000804372,0.0003255999,0.00007259694,0.0001914508,0.000005999768,0.000173445,0.00008596905,0.0002974273],"category_scores_gemma":[0.004816391,0.00005703214,0.0000994052,0.0001845325,0.0005462864,0.0001649157,0.0001506223,0.001071384,0.000003684354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002894466,"about_ca_system_score_gemma":0.0003857562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002184455,"about_ca_topic_score_gemma":0.00003561776,"domain_scores_codex":[0.9970635,0.001741703,0.0007917803,0.0000832053,0.0001754376,0.0001443991],"domain_scores_gemma":[0.9915844,0.007227686,0.0006869769,0.0002108067,0.0002322685,0.00005785415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6187146,0.007401985,0.3051544,0.00002831008,0.01932702,0.005234639,0.003238941,0.0001728612,0.006805659,0.001676031,0.005705533,0.02653997],"study_design_scores_gemma":[0.003158522,0.004952712,0.9757383,0.00004635285,0.0005753248,0.004392204,0.005219269,0.00001594197,0.00004049466,0.0002915059,0.005505768,0.00006357786],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843609,0.01045287,0.000004759566,0.004595865,0.0003734144,0.00007811726,0.00001391589,0.000004770093,0.0001154039],"genre_scores_gemma":[0.9915527,0.00749966,0.00008890907,0.0007399761,0.00005316989,0.00000189684,0.000003044416,0.000007990659,0.00005269387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6705839,"threshold_uncertainty_score":0.5766018,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03001278810058661,"score_gpt":0.373190354969632,"score_spread":0.3431775668690454,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}